E- cadherin mutation is seen in which type of carcinoma:
**Core Concept**
E-cadherin is a transmembrane glycoprotein that plays a crucial role in cell-cell adhesion, particularly in epithelial tissues. Mutations in the E-cadherin gene (CDH1) can lead to a loss of cell adhesion, resulting in the disruption of tissue architecture and the development of cancer.
**Why the Correct Answer is Right**
The correct answer is related to lobular breast carcinoma, a type of breast cancer characterized by the loss of E-cadherin function. This loss leads to the disruption of normal cell-cell adhesion, resulting in the formation of isolated tumor cells that grow in a single-file pattern. The CDH1 gene mutations are inherited in an autosomal dominant pattern, and individuals with these mutations have a significantly increased risk of developing lobular breast carcinoma. The absence of E-cadherin expression is a hallmark of this cancer type.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because E-cadherin mutations are not typically associated with squamous cell carcinoma, which is characterized by a different set of genetic mutations and histological features.
* **Option B:** This option is incorrect because E-cadherin mutations are not typically associated with colorectal cancer, which is often driven by mutations in the APC gene and other genetic alterations.
* **Option C:** This option is incorrect because E-cadherin mutations are not typically associated with ovarian cancer, which is a complex disease driven by a variety of genetic and molecular alterations.
**Clinical Pearl / High-Yield Fact**
It's essential for clinicians to recognize that E-cadherin mutations are associated with a distinct clinical phenotype, including a high risk of bilateral breast cancer and a family history of lobular breast cancer.
**Correct Answer: D. Lobular breast carcinoma.**